Identification and Determination of Impurities in a New Therapeutic Agent for Fatty Liver Disease

Figure 2

HPLC chromatogram of IMM and its impurities: (a) (i) IMM crude substances (0.5 mg/mL) and (ii) blank; (b) oxidative degradation of IMM (30% H₂O₂).

(a)

(b)